Search hospitals
>
Michigan
>
Livonia
Trinity Health Saint Mary Mercy Livonia Hospital
Claim this profile
Livonia, Michigan 48154
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
494 reported clinical trials
8 medical researchers
Summary
Trinity Health Saint Mary Mercy Livonia Hospital is a medical facility located in Livonia, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Trinity Health Saint Mary Mercy Livonia Hospital is involved with conducting 494 clinical trials across 494 conditions. There are 8 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Area of expertise
Lung Cancer
Trinity Health Saint Mary Mercy Livonia Hospital has run 93 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Trinity Health Saint Mary Mercy Livonia Hospital has run 88 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Tareq Al Baghdadi
Genesys Hurley Cancer Institute
9 years of reported clinical research
Christopher M. Reynolds, MD
Saint Joseph Mercy Hospital
3 years of reported clinical research
Philip J. Stella
Saint Joseph Mercy Hospital
5 years of reported clinical research
Elie G. Dib
Genesys Hurley Cancer Institute
7 years of reported clinical research
Clinical Trials running at Trinity Health Saint Mary Mercy Livonia Hospital
Lung Cancer
Breast Cancer
Breast cancer
Prostate Cancer
Bladder Cancer
Cancer
Esophageal cancer
Kidney Cancer
Ovarian Cancer
Pancreatic Cancer
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting
2 awards
Phase 3
10 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Trinity Health Saint Mary Mercy Livonia Hospital?
Trinity Health Saint Mary Mercy Livonia Hospital is a medical facility located in Livonia, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Trinity Health Saint Mary Mercy Livonia Hospital is involved with conducting 494 clinical trials across 494 conditions. There are 8 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Trinity Health Saint Mary Mercy Livonia Hospital located?
**Directions to Trinity Health Livonia Hospital, Livonia, Michigan:** - Take I-96 East to the Levan/Newburgh exit. - Turn left onto Levan North. - The hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Trinity Health Saint Mary Mercy Livonia Hospital, please reach out to the Patient Accounting Department at (740) 283-7261 or the Financial Counselor at (740) 264-8326. The Financial Assistance Application is accessible in multiple languages. For additional support, email [email protected].
What insurance does Trinity Health Saint Mary Mercy Livonia Hospital accept?
Trinity Health Saint Mary Mercy Livonia Hospital accepts a wide range of insurance plans, including but not limited to Aetna U.S. Healthcare, Anthem/Blue Cross Blue Shield, Humana, United Healthcare, Medicare A & B, Tricare, VA, Amerigroup Community Care, Medicaid of Georgia, and Peach State Health Plan. Coverage options extend across various categories such as traditional managed care plans, Medicare or Medicare Advantage, Medicaid or a Medicaid CMO, and Health Insurance Exchange plans. For the most current and comprehensive list of accepted insurance plans, contacting the hospital directly or visiting their website is recommended.
What awards or recognition has Trinity Health Saint Mary Mercy Livonia Hospital received?
Trinity Health Saint Mary Mercy Livonia Hospital, located in Livonia, Michigan, is renowned for its dedication to patient safety, earning an "A" grade from the Leapfrog Group in its spring 2020 Hospital Safety Grades report. The hospital is part of Trinity Health, where 13 hospitals received "A" grades for patient safety. It also fosters a culture of research and scholarly activity, highlighted by its annual Resident Research Forum, allowing residents to showcase their research projects.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.